‘Historic’ White House Announcement on Autism and Tylenol Causes Confusion
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The independent source for health policy research, polling, and news.
81 - 100 of 516 Results
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
This week, the FDA began the process of approving leucovorin, an inexpensive, generic drug derived from folic acid, to help children diagnosed with autism.
In a rambling news conference that shocked public health experts, President Donald Trump — without scientific evidence — blamed the over-the-counter drug acetaminophen, and too many childhood vaccines, for the increase in autism diagnoses in the U.S. That came days after a key immunization advisory panel, newly reconstituted with vaccine doubters, changed several long-standing recommendations. Former Centers for Disease Control and Prevention official Demetre Daskalakis joins KFF Health News’ Julie Rovner to discuss those stories. Meanwhile, Sandhya Raman of CQ Roll Call and Anna Edney of Bloomberg News join Rovner with the rest of the news, including a threat by the Trump administration to fire rather than furlough federal workers if Congress fails to fund the government beyond the Oct. 1 start of the new fiscal year.
The decisions by the Advisory Committee on Immunization Practices matter, because insurers and federal programs rely on them, but they are not binding. States can follow the recommendations, or not.
Doctors say acetaminophen, the main ingredient in Tylenol, is safe to take during pregnancy. Other over-the-counter pain relievers such as aspirin and ibuprofen aren’t recommended because they can harm fetal development. Untreated fever in pregnancy can pose maternal and fetal health risks.
The White House’s autism announcement exaggerates links to Tylenol, misleads on vaccines, and sets back the field by ignoring decades of research, scientists say.
A Centers for Disease Control and Prevention meeting on vaccines pitted scientific expertise against vaccine skepticism. An often confusing debate ended with critics of the current vaccine schedule tabling a vote to remove one of its cornerstones.
A lack of faith in the soundness of the Centers for Disease Control and Prevention’s new direction has led states to explore enacting their own vaccine policies. A patchwork of divergent recommendations and requirements could result.
Susan Monarez and former Centers for Disease Control and Prevention chief medical officer Debra Houry described turmoil in an agency dominated by anti-vaccine political officials nominated by Health and Human Services Secretary Robert F. Kennedy Jr.
A federal vaccine panel, recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., is expected to vote on delaying the hepatitis B shot for newborns. Pediatricians warn that could open the door to a comeback for a disease virtually eradicated among U.S. children.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
With less than three weeks before the deadline to pass legislation to keep the federal government running, lawmakers are still far apart on a strategy. Democrats hope Republicans will agree to extend expanded tax credits for the Affordable Care Act as part of a compromise, but so far Republicans are not negotiating. Meanwhile, HHS Secretary Robert F. Kennedy Jr. released his long-awaited “Make America Healthy Again” report, with few specific action items. Anna Edney of Bloomberg News, Sandhya Raman of CQ Roll Call, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more.
Although the FDA has approved the vaccines for anyone 65 or older and anyone at least 6 months old who is at risk of a severe covid infection, barriers to coverage and access persist.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
A combative Robert F. Kennedy Jr, the U.S. secretary of health and human services, appeared before a Senate committee Thursday, defending his firing of the newly confirmed director of the Centers for Disease Control and Prevention as well as other changes that could limit the availability of vaccines. Meanwhile, Congress has only a few weeks to complete work on annual spending bills to avoid a possible government shutdown and to ward off potentially large increases in premiums for Affordable Care Act health plans. Jessie Hellmann of CQ Roll Call, Sarah Karlin-Smith of Pink Sheet, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who discusses his “Bill of the Month” report about a woman’s unfortunate interaction with a bat — and her even more unfortunate interaction with the bill for her rabies prevention treatment.
KFF Health News’ Stephanie Armour, Julie Rovner, and Arthur Allen and KFF’s Josh Michaud discuss the biggest takeaways from Robert F. Kennedy Jr.’s hearing before the Senate Finance Committee.
The White House and congressional Republicans have made historic changes to the federal anti-hunger program SNAP. They say the changes will boost healthy eating for low-income Americans. Some nutrition experts aren’t so sure.
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
© 2026 KFF